Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q2 EPS by 54c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.59), $0.54 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
• MagnaChip (MX) files $50M mixed shelf